Compounds > tuftsin

Page last updated: 2024-09-04

tuftsin and amphotericin b

tuftsin has been researched along with amphotericin b in 10 studies

Compound Research Comparison

Studies (tuftsin)	Trials (tuftsin)	Recent Studies (post-2010) (tuftsin)	Studies (amphotericin b)	Trials (amphotericin b)	Recent Studies (post-2010) (amphotericin b)
534	4	58	17,210	673	4,294

Research

Studies (10)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (10.00)	18.2507
2000's	9 (90.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ahmed, I; Bachhawat, BK; Gupta, CM; Jain, RK; Krishnakumar, B; Owais, M	1
Agrawal, AK; Gupta, CM	1
Agrawal, A; Agrawal, AK; Gupta, CM; Guru, PY; Pal, A	1
Faisal, SM; Haque, W; Masood, AK; Owais, M	1
Haq, W; Khan, MA; Nasti, HT; Owais, M; Saima Dagger, K; Shehbaz, A; Syed, FM	1
Firoz, A; Jabeen, R; Khan, MA; Mohammad, O	1
Ahmad, N; Khan, A; Khan, MA; Mannan, A; Moin, S; Owais, M; Pasha, ST; Wajahul, H	1
Khan, MA; Nasti, TH; Owais, M	1
Khan, MA; Owais, M	2

Reviews

1 review(s) available for tuftsin and amphotericin b

Article	Year
Tuftsin-bearing liposomes in treatment of macrophage-based infections. Advanced drug delivery reviews, 2000, Mar-30, Volume: 41, Issue:2 Topics: Amphotericin B; Animals; Drug Carriers; Drug Delivery Systems; Humans; Leishmaniasis; Liposomes; Macrophages; Malaria; Mycoses; Tuberculosis; Tuftsin	2000

Other Studies

9 other study(ies) available for tuftsin and amphotericin b

Article	Year
Tuftsin-bearing liposomes as drug vehicles in the treatment of experimental aspergillosis. FEBS letters, 1993, Jul-12, Volume: 326, Issue:1-3 Topics: Amino Acid Sequence; Amphotericin B; Animals; Aspergillosis; Aspergillus fumigatus; Drug Carriers; Humans; Liposomes; Macrophage Activation; Male; Mice; Mice, Inbred BALB C; Molecular Sequence Data; Tuftsin	1993
Superior chemotherapeutic efficacy of amphotericin B in tuftsin-bearing liposomes against Leishmania donovani infection in hamsters. Journal of drug targeting, 2002, Volume: 10, Issue:1 Topics: Amphotericin B; Animals; Antiprotozoal Agents; Cricetinae; Drug Carriers; Leishmania donovani; Leishmaniasis, Visceral; Liposomes; Macrophages; Male; Mesocricetus; Tuftsin	2002
Immunomodulator tuftsin augments anti-fungal activity of amphotericin B against experimental murine candidiasis. Journal of drug targeting, 2002, Volume: 10, Issue:3 Topics: Adjuvants, Immunologic; Amphotericin B; Animals; Antifungal Agents; Antigens; Candida albicans; Candidiasis; Disease Models, Animal; Drug Resistance, Fungal; Drug Synergism; Female; Immunoglobulin G; Kidney; Liposomes; Liver; Lung; Mice; Mice, Inbred BALB C; Ovalbumin; Spleen; T-Lymphocytes; Tuftsin	2002
Use of tuftsin bearing nystatin liposomes against an isolate of Candida albicans showing less in vivo susceptibility to amphotericin B. Journal of drug targeting, 2003, Volume: 11, Issue:2 Topics: Adjuvants, Immunologic; Amphotericin B; Animals; Antibiotic Prophylaxis; Antifungal Agents; Candida albicans; Candidiasis; Cholesterol; Chromatography, High Pressure Liquid; Female; Liposomes; Mice; Mice, Inbred BALB C; Nystatin; Phosphatidylcholines; Tuftsin	2003
Prophylactic role of immunomodulators in treatment of systemic candidiasis in leukopenic mice. Journal of drug targeting, 2004, Volume: 12, Issue:7 Topics: Amphotericin B; Animals; Antifungal Agents; Candida albicans; Candidiasis; Drug Compounding; Drug Resistance, Fungal; Female; Immunologic Factors; Intercalating Agents; Kidney; Leukopenia; Lipopolysaccharides; Liposomes; Male; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Nystatin; Staphylococcal Protein A; Tuftsin	2004
Tuftsin-mediated immunoprophylaxis against an isolate of Aspergillus fumigatus shows less in vivo susceptibility to amphotericin B. FEMS immunology and medical microbiology, 2005, Jun-01, Volume: 44, Issue:3 Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Drug Evaluation, Preclinical; Drug Therapy, Combination; Immunocompromised Host; Immunologic Factors; Liposomes; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Tuftsin	2005
Incorporation of amphotericin B in tuftsin-bearing liposomes showed enhanced efficacy against systemic cryptococcosis in leucopenic mice. The Journal of antimicrobial chemotherapy, 2005, Volume: 56, Issue:4 Topics: Amphotericin B; Animals; Antifungal Agents; Brain; Cryptococcosis; Dose-Response Relationship, Drug; Drug Synergism; Immunologic Factors; Leukocytes; Leukopenia; Liposomes; Lung; Mice; Mice, Inbred BALB C; Tuftsin	2005
Immunomodulator tuftsin increases the susceptibility of Cryptococcus neoformans to liposomal amphotericin B in immunocompetent BALB/c mice. Journal of drug targeting, 2005, Volume: 13, Issue:7 Topics: Amphotericin B; Animals; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Drug Therapy, Combination; Female; Immunocompetence; Immunologic Factors; Liposomes; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Tuftsin	2005
Toxicity, stability and pharmacokinetics of amphotericin B in immunomodulator tuftsin-bearing liposomes in a murine model. The Journal of antimicrobial chemotherapy, 2006, Volume: 58, Issue:1 Topics: Amphotericin B; Animals; Antifungal Agents; Candidiasis; Deoxycholic Acid; Dose-Response Relationship, Drug; Drug Combinations; Drug Stability; Immunologic Factors; Liposomes; Mice; Mice, Inbred BALB C; Tuftsin	2006